DNLI · Denali Therapeutics Inc.
$24.35
-0.05 (-0.20%)
At close · Aug 17
Market Cap
$3.88B
Shares
159.85M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-16 | 40 | $23.02 | $921 |
| 2026-07-13 | 92 | $25.68 | $2,363 |
| 2026-07-02 | 439 | $25.98 | $11,405 |
| 2026-07-01 | 60 | $25.72 | $1,543 |
| 2026-06-30 | 191 | $25.89 | $4,945 |
| 2026-06-26 | 28 | $24.73 | $692 |
| 2026-06-24 | 7,431 | $24.77 | $184,066 |
| 2026-06-22 | 315 | $23.31 | $7,343 |
| 2026-06-15 | 106 | $21.66 | $2,296 |
| 2026-06-11 | 49 | $20.61 | $1,010 |
| 2026-06-10 | 184 | $20.79 | $3,825 |
| 2026-06-08 | 30,328 | $19.52 | $592,003 |
| 2026-06-03 | 1,327 | $19.35 | $25,677 |
| 2026-06-02 | 2,722 | $20.41 | $55,556 |
| 2026-05-27 | 179,418 | $19.38 | $3,477,121 |
| 2026-05-18 | 217 | $18.62 | $4,041 |
Showing 1–16 of 16 settlements
Key facts
CIK
1714899
CUSIP
24823R105
13F (30d)
275 filings
271 filers
Visit website
Investor relations